BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,096,000 | +289.0% | 6,859,000 | +323.9% | 0.06% | +323.1% |
| Q2 2019 | $1,824,000 | +9.4% | 1,618,000 | +10.7% | 0.01% | -7.1% |
| Q1 2019 | $1,668,000 | +3968.3% | 1,462,000 | +4077.1% | 0.01% | – |
| Q2 2018 | $41,000 | -98.0% | 35,000 | -98.0% | 0.00% | -100.0% |
| Q1 2017 | $2,098,000 | -30.8% | 1,768,000 | -26.8% | 0.02% | 0.0% |
| Q3 2016 | $3,030,000 | +273.2% | 2,414,000 | +300.3% | 0.02% | +220.0% |
| Q4 2015 | $812,000 | -86.3% | 603,000 | -84.6% | 0.01% | -84.8% |
| Q1 2015 | $5,939,000 | +180.9% | 3,922,000 | +103.1% | 0.03% | +135.7% |
| Q3 2014 | $2,114,000 | +4597.8% | 1,931,000 | +4497.6% | 0.01% | – |
| Q4 2013 | $45,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |